IL10 and myeloid sarcoma: A genetic vaccine containing the hsp65 mycobacterial gene resulted able to reduce EAE clinical signs and trigger higher IL-10 production in the CNS, thus, evidencing how IL-10 may represent one of the most effective anti-inflammatory cytokines for MS control [99].